Epitope gets oral-HIV approvable letter:
This article was originally published in Clinica
The US FDA has sent an approvable letter to Epitope for use of OraSure, its oral HIV sample collection system, with its Western blot test. Epitope must submit additional information and pass an inspection before approval is granted.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.